Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 7, 2025

New Healthcare Resource Launches: NationalHealthRatings.com Empowers Patients with Transparent Hospital Ratings
SANTA BARBARA, CA, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- With the launch of NationalHealthRatings.com/hospitals, patients, and families now have a powerful new tool for navigating healthcare decisions. This comprehensive platform ranks and …

Savant to Showcase Agentic AI Analytics Platform at Tableau Conference 2025
Savant Unveils Agentic AI Analytics Innovation and Customer Use Cases to 7,000+ Attendees SAN MATEO, CA, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- Savant, a leading agentic AI analytics platform, is pleased to announce its participation in …

TENEX.AI Appoints Venkata Koppaka as CTO to Accelerate AI-Powered MDR During Rapid Expansion
Venkata Koppaka joins TENEX.AI as CTO to scale its AI-powered MDR platform amid rapid growth and rising demand for next-gen AI powered cybersecurity services. SAN JOSE, CA, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- TENEX.AI, a rapidly growing …

LOUD Capital Acquires Infinite CXO to Launch LOUD Collective: A Comprehensive Business Value Ecosystem
LOUD Capital proudly announces the launch of LOUD Collective, a full-service ecosystem to drive business growth from inception to exit. COLUMBUS, OH, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- LOUD Capital is delighted to announce the formation …

Beautinow Launches AI-Powered Sunscreen Advisor & Sun Protection Guide
Beautinow, an online leader in premium skincare, releases its 2025 Sun Protection …

Landmark Research by Stanford, Yale, and DeepMind Align with XMPro's Brain-Inspired Foundation Agents
Industrial AI at the Inflection Point: XMPro's Approach Validated by Stanford, Yale Research DALLAS, TX, UNITED STATES, April 7, 2025 /EINPresswire.com/ -- XMPro, a leader in industrial AI solutions, today announced that its Multi-Agent Generative …

Dundee Precious Metals Announces First Quarter 2025 Production Results
TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (“DPM” or “the Company”) announced preliminary production results from both of its mines for the quarter ended March 31, 2025. “With solid gold production in the first …

Helios Fairfax Partners Announces Appointment of Michael Corcoran as Interim Chief Financial Officer
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 07, 2025 (GLOBE NEWSWIRE) -- Helios Fairfax Partners Corporation (TSX: HFPC.U) (“HFP”) today announced the appointment of Michael Corcoran as Interim …

Avicanna Announces Receipt of Management Cease Trade Order and Provides Bi-Weekly Status Update
Auditor Licensing …

StarMab BioMed’s First-in-Class, Dual-Target Anti-Tumor Drug SM2275 for Novel Immunotherapy Receives FDA IND Approval
StarMab announces that US FDA has approved its Investigational New Drug (IND) application for SM2275, a novel dual-target nanobody-based anti-tumor therapy. BEIJING, CHINA, April 7, 2025 /EINPresswire.com/ -- Beijing StarMab BioMed Technology , Ltd. (“ …

Jeune Aesthetics Appoints Marc Forth as Chief Executive Officer
PITTSBURGH, April 07, 2025 (GLOBE NEWSWIRE) -- Jeune Aesthetics, Inc. (“Jeune”), a wholly owned subsidiary of Krystal Biotech, Inc. (“Krystal”) (NASDAQ: KRYS) leveraging Krystal’s clinically validated gene-delivery platform to fundamentally address and …

Oragenics, Inc. Participates in the 3rd Nasal Formulation & Delivery Summit
SARASOTA, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biotechnology company focused on developing novel intranasal therapies for brain-related disorders, today announced that Chief Medical Officer Dr. James Kelly …

Pacira BioSciences Announces Settlement of U.S. Patent Litigation for EXPAREL
-- Fresenius Kabi licensed to sell volume-limited amounts of generic bupivacaine liposome injectable suspension in the U.S. no earlier than a confidential date in 2030 -- -- Fresenius also licensed to sell generic bupivacaine liposome injectable suspension …

Innventure, Inc. to Announce Fourth Quarter and Full Year 2024 Results on April 11
ORLANDO, Fla., April 07, 2025 (GLOBE NEWSWIRE) -- Innventure, Inc. (NASDAQ: INV) (“Innventure”), a differentiated technology commercialization platform, today announced it will release its fourth quarter and full year 2024 financial results before market …

Sprout Social to Announce First Quarter 2025 Financial Results on May 8, 2025
CHICAGO, April 07, 2025 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that it will report its financial results for the …

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Pliant Therapeutics Announces Upcoming Presentations at the 2025 American Thoracic Society International Conference
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 American Thoracic Society (ATS) International Conference, …

Astec Industries, Inc. Announces the Company’s First Quarter 2025 Conference Call on April 29, 2025, at 8:30 A.M. Eastern Time
CHATTANOOGA, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- You are invited by Astec Industries, Inc. (NASDAQ:ASTE) to participate in a conference call to review the company’s first quarter 2025 financial results. Astec Industries, Inc. will be releasing the …

Study of Pre- and Post-Rehabilitation of Cured-In-Place Pipe for Florida Utility Shows 63% Increase in Infiltration
Landmark 4-Year Study of CCTV …

Tevogen Bio Highlights Most Recent Insider Ownership of 74%; Management Maintains Conviction in the Company’s Mission
WARREN, N.J., April 07, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, is unified by a commitment to advancing patient- …